Bayh-Dole Act Casting a Shadow Over New COVID-19 Medical Developments
November 05, 2020
Historically, circumstances under which a federal agency has requested transfer of patent title under the amended Bayh-Dole Act have been rare. However, times and circumstances have changed. On this episode, patent partner, Jeff Morton, discusses the possibility of a federal agency requesting transfer of title for a patent that covers COVID-19 antibody treatment.